JHVEPhoto Canopy Growth Corporation (NASDAQ:CGC) would see its commons rally as high as $15 per share in the spring on the back of enthusiasm over the Drug Enforcement Administration (“DEA”) proposal to reschedule cannabis. The uncertainty with the late April report on the proposal to reclassify cannabis to the lower-risk Schedule III grouping was always […]
The post Canopy Growth: Dilution, Executive Turnover, Cannabis Rescheduling Delay End High (CGC) appeared first on News Portal NYC.